Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01807052 · ClinicalTrials.gov registry record
Biomarker Expression in Tissue Samples From Patients With Bone Sarcomas
A clinical trial, sponsored by Children's Oncology Group.
- Completed
- Registry status
- 34
- Enrollment target
NCT01807052: Completed study, sponsored by Children's Oncology Group.
NCT01807052 is a clinical trial that has completed, run by Children's Oncology Group. The registered enrollment target is 34 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01807052 has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- 34 participants
- Enrollment target
Study Summary
This trial studies biomarker expression in tissue samples from patients with bone sarcomas. Studying biomarker in tissue samples from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer
Primary Outcome
Estimated in the analytic population as the number of samples in the population in which such expression is noted divided by 33. An assessment of the precision of such estimates will be provided by an exact binomial confidence interval. Comparison of normalized TF expression in non-metastatic versus metastatic patients will be done using the two-sample t-test.
Interventions
- OTHER laboratory biomarker analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2009-11 |
| Est. Completion | 2016-05 |
What the finished NCT01807052 record still lists
NCT01807052 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 34 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which laboratory biomarker analysis is the first listed.
NCT01807052 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01807052 about?
NCT01807052 is a clinical study titled "Biomarker Expression in Tissue Samples From Patients With Bone Sarcomas". This trial studies biomarker expression in tissue samples from patients with bone sarcomas. Studying biomarker in tissue samples from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer
What is the current status of trial NCT01807052?
This trial is currently completed. The enrollment target is 34 participants. The study started on 2009-11. Estimated completion is 2016-05.
What interventions are being tested in trial NCT01807052?
The interventions under investigation include: laboratory biomarker analysis (OTHER).
Who is sponsoring clinical trial NCT01807052?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia